https://e-sygoing.link Latest links in the Research and Development category en-us Fri, 22 May 2026 13:30:52 -0400 https://e-sygoing.link/link/5624225-favrille-inc Biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. Thu, 16 Oct 2025 18:22:56 -0400 https://e-sygoing.link/go/5624225 https://e-sygoing.link/link/5624226-serenex-inc Drug discovery and development through the commercialization of chemoproteomics, fractionation and mining, purine-binding, mechanism of action determination, and toxicity screening. Sat, 08 Feb 2025 08:26:12 -0500 https://e-sygoing.link/go/5624226 https://e-sygoing.link/link/5624223-dendreon-corp Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN) Mon, 25 Nov 2024 03:46:17 -0500 https://e-sygoing.link/go/5624223 https://e-sygoing.link/link/5624229-heal-corporation Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington. Thu, 10 Oct 2024 16:11:39 -0400 https://e-sygoing.link/go/5624229 https://e-sygoing.link/link/5624224-osi-pharmaceuticals-inc Researches and develops diagnostics and anticancer therapy in humans and other diseases associated with control of cell growth. Laboratories in Oxford, Boulder and Farmingdale, headquartered in Melville, New York. (Nasdaq: OSIP) Tue, 08 Oct 2024 08:38:54 -0400 https://e-sygoing.link/go/5624224 https://e-sygoing.link/link/5624227-panacea-pharmaceuticals-inc Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need. Sun, 03 Mar 2024 05:51:57 -0500 https://e-sygoing.link/go/5624227 https://e-sygoing.link/link/5624218-exelixis-inc Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL) Fri, 05 Jan 2024 04:30:47 -0500 https://e-sygoing.link/go/5624218 https://e-sygoing.link/link/5624220-immunogen-inc Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN) Sat, 01 Jul 2023 04:16:11 -0400 https://e-sygoing.link/go/5624220